This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Reboli A, Rotstein C, Kett D, Shorr A, Chambers R, Hux M, Maschio M, Tarallo M.Economic evaluation of anidulafungin (Eraxis Rm) versus intravenous fluconazole in the treatment of hospital inpatients diagnosed with candidaemia and other forms of invasive candidiasis. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 79989, 18 May 2009. Available from: URL: http://www.akm.ch/eccmid2009
Grau S, Garcia-Vargas M, Marti B, Mir N.Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain. 19th European Congress of Clinical Microbiology and Infectious Diseases: abstr. 87896, 18 May 2009. Available from: URL: http://www.akm.ch/eccmid2009
Rights and permissions
About this article
Cite this article
Anidulafungin cost effective for candidaemia and candidiasis. Pharmacoecon. Outcomes News 580, 4 (2009). https://doi.org/10.2165/00151234-200905800-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00009